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Abstract – This paper presents the fabrication of 
controlled release devices for anticancer drug paclitaxel 
using supercritical antisolvent method. The 
thermodynamic and hydrodynamic effects during 
supercritical antisolvent process on the particle properties 
obtained were investigated. Scanning electron microscopy 
was employed to study particle sizes and morphologies 
achieved. It was observed that increasing supercritical 
pressure improves the surface morphology of particles 
obtained, and increasing the flow rate of the organic 
solution jet reduces the particle sizes obtained. A modified 
Supercritical Antisolvent with Enhanced Mass transfer 
setup was developed to produce monodispersed 
nanoparticles with high recovery yield. High performance 
liquid chromatography was used to determine the 
encapsulation efficiency and in vitro release profiles of 
paclitaxel loaded particles obtained. The encapsulation 
efficiencies of particles obtained using the modified 
SASEM process were high and up to 83.5%, and sustained 
release of paclitaxel from the polymer matrix was 
observed over 36 days release. The thermogram properties 
of the particles were also analyzed using differential 
scanning calorimetry to determine the crystalline state of 
polymer and drug. 
 
 
Index terms – supercritical antisolvent, controlled release 
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I. INTRODUCTION 
Particle formation is an important application of 
supercritical fluid technology [1]. Favorable properties of 
supercritical fluids for particle formation include liquid-like 
density and gas-like viscosity [2]. The well known techniques 
for particle formation using supercritical fluids include the 
rapid expansion of supercritical solutions (RESS) [1 – 4] and 
the supercritical antisolvent (SAS) processes [1 – 3, 5 – 13]. 
The most commonly used supercritical fluid in pharmaceutical 
applications is CO2, which is attributed to its desirable 
properties such as relatively accessible critical point (Tc = 
31.1 oC, Pc = 73.8 bars), abundance and its low toxicity [1 – 3]. 
Since most organic solvents are miscible with CO2 at 
supercritical conditions, a low residual solvent content can 
be easily achieved in the final product without extensive 
downstream purification to remove excess organic solvent 
[14].   
 
Several factors may affect the particle size and 
properties achieved from SAS process. This includes the 
phase behavior of the ternary mixture, the hydrodynamics 
of the solution injected into the supercritical phase, as well 
as the thermodynamic conditions of the supercritical fluid. 
Considerable literature suggests that the controlling 
parameter for particle size in the SAS process is the rate of 
mass transfer [12, 13]. This may be influenced by both the 
spray hydrodynamics and thermodynamic properties of the 
supercritical fluid phase. Diego et al. [15] reported the 
mechanism of particle formation in subcritical and 
supercritical regimes for precipitation from compressed 
antisolvent (PCA) process. The jet breakup for operation in 
subcritical and supercritical conditions was different and 
hence particles properties were different. The effect of 
flow rate on particle size in the subcritical regime was 
reported. Carretier et al. [16] investigated the 
hydrodynamics of the SAS process by evaluating the 
macro and micromixing within the precipitation vessel. 
Varying liquid flow rates were studied for their effect on 
jet breakup lengths and particle properties. It was shown 
that fibers or microparticles may be obtained in their 
studies depending on liquid flow rate. Similar studies have 
been carried out to investigate the influence of enhanced 
mixing of the spray jet with supercritical CO2 using 
coaxial nozzles [13] and ultrasonic nozzles [5, 6]. These 
processes were found to yield smaller and more uniform 
sized particles as compared to conventional SAS. 
Chattopadhyay and Gupta [7 – 11] used an ultrasonic 
vibrating surface to break up the solution jet into smaller 
droplets and also increase the mass transfer rates between 
supercritical CO2 and organic solvent. This has been 
termed the supercritical antisolvent with enhanced mass 
transfer process (SASEM).  
 
In this study, SAS and a modified SASEM process was 
developed to fabricate micro and nanoparticles of a 
biodegradable and biocompatible polymer Poly L lactide  
(PLA). The main difference between the modified process and 
the usual SASEM process is that the organic solution spray 
was directed away from the ultrasonic vibrating surface. The 
atomization of the inlet solution was achieved by jet breakup 
at supercritical pressures and not due to ultrasonic liquid 
atomization of a liquid level at the vibrating surface. The 
ultrasonic probe is fitted into the high pressure vessel to create 
extensive mixing and turbulence within the vessel during the 
modified SASEM process. The organic solution was 
introduced into the high pressure vessel through a 500 µm ID 
stainless steel capillary. The high pressure vessel has 
borosilicate glass windows which allow observation of the 
SAS and the modified SASEM process. 
 
 
 
II.MATERIALS AND METHODS 
A.  Materials 
Poly (L-lactic acid) (PLA, Product Number P1566, MW = 
85,000 – 160,000 Da) was purchased from Sigma Aldrich. 
polyethylene glycol (PEG, Product number P4463, Typical 
MW = 8,000 Da) were purchased from Sigma Aldrich. 
Paclitaxel was a generous gift from Bristol Myers Squibb. 
Compressed CO2 (Alphagaz) was purchased from Soxal 
(Singapore Oxygen Air Liquide Pte Ltd). Dichloromethane 
(DCM, Product Number DS1432, HPLC/Spectro Grade) and 
acetonitrile (ACN, Product Number AS1122, HPLC/Spectro 
Grade) were purchased from Tedia (Tritech Scientific Pte Ltd, 
Singapore). Phosphate buffered saline (PBS) was purchased 
from Sigma Aldrich (pH = 7.4). Millipore water was used 
throughout the study.  
 
B.  Microparticles and nanoparticles preparation 
The experimental equipment for the SAS and modified 
SASEM processes is shown in Figure 1a and 1b respectively. 
Table 1 summarizes the main differences between the present 
setup and the SASEM process. Paclitaxel and PLA were 
first dissolved in DCM. Theoretical drug to polymer 
loadings of 5 and 10% (w/w), and polymer to solvent 
loadings of 1 and 2% (w/v) were used in the experiments 
performed.  
 
The high pressure vessel was first purged and filled with 
compressed CO2 (50 – 60 bars). Liquefied CO2 was 
subsequently pumped into the vessel by a high pressure 
pump to attain the required pressure. The temperature in 
the vessel was controlled by use of a heated water bath. 
Ultrasonic vibration amplitude of 0 – 90 µm was used in 
the experiments with modified SASEM setup. The organic 
solution was pumped into the high pressure vessel at a 
flow rate of 2 to 6 ml/min through a capillary tubing of ID 
500µm.  
 
After the batch precipitation process, the DCM-CO2 
mixture was vented off to a fume cupboard. Fresh CO2 was 
introduced into the vessel at 50 bars for 3 times to remove 
any residual DCM in the particles. The particles were 
collected at the bottom of the vessel on a 0.22 µm cellulose 
acetate filter during the venting process. 
 
C. Size and Surface morphology analysis 
Qualitative observation of the size and surface 
morphology of the particles was achieved by scanning 
electron microscopy (SEM) (JEOL JSM-5600 LV). 
Platinum coating (Autofine Coater, JEOL JFC-1300) of 
the samples was required before SEM analysis. The 
particle size and size distribution was determined using 
SMILEVIEW software on the SEM pictures captured. 
 
D. Thermogram properties analysis 
Phase behavior of the particles was studied by 
differential scanning calorimetry (DSC) (2920 modulated, 
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Fig. 1.  Experimental setup for (a) Supercritical antisolvent (SAS) production of micro and nanoparticles of PLA  
(b) Modified supercritical antisolvent with enhanced mass transfer (SASEM) setup 
 
HP: Jerguson 12-T-32 high pressure vessel (For supercritical antisolvent process); U1: Ultrasonic system; Branson sonifier and converter, Sonics and 
Materials probe (3/8” probe tip diameter); C1: Polyscience 912 refrigerating circulator (for liquefying CO2); C2: Polyscience 712 circulator with 
temperature control (Water bath); P1: Eldex B-100-S HP series pump (for solution injection); P2: Jasco HPLC pump (for pumping liquefied CO2 into HP 
vessel); F1: 0.22 micron filter membrane (to collect particles from bottom of vessel); F2: stainless steel filter (0.22 micron, for filtering the contents leaving 
the vessel); V1: Swagelok 1/16” tube connection ball valve (solution line);V2: Swagelok 1/16” tube connection ball valve (CO2 line); V3: Swagelok 1/8” 
tube connection ball valve (to vent); TC: Thermocouple connected to Thermometer read out; PI: Swagelok Pressure gauge 
 
Universal V2.6D TA instruments). Approximately 2-10 mg of 
particles was loaded onto standard aluminum pans (40mg) 
with lids. The samples were purged with pure dry nitrogen at 
flow rate of 5 ml/min. A blank aluminum pan was used as 
reference in all the experiments. The analysis was carried out 
using a temperature ramp of 10 oC/min from 20 – 280 oC.  
 
E. Encapsulation efficiency and in vitro release profile 
High pressure liquid chromatography (HPLC) (Agilent 
HPLC Series 1100 with UV-visible detectors) was used to 
determine the encapsulation efficiency and in vitro release 
profile of the paclitaxel-loaded PLA particles. An acetonitrile : 
water (50 : 50 v/v%) solution was used as the mobile phase.  
 
Encapsulation efficiency of each paclitaxel-loaded sample 
was carried out in triplicate. Approximately 0.5 mg of sample 
was weighed and dissolved in 0.5ml DCM to extract the 
paclitaxel embedded in the polymer matrix. After all the DCM 
has evaporated, 5ml of mobile phase was added and placed in 
an ultrasonic water bath to dissolve the paclitaxel in the 
mobile phase. Subsequently, 2ml of the solution was filtered 
(0.22µm syringe filters) into HPLC vials for analysis. The 
HPLC column was calibrated for peak area at paclitaxel 
concentrations of 1, 5, 10, 40, 60, 80 and 100 µg/ml in the 
mobile phase. 
 
The in vitro release profile was also determined in triplicate. 
Approximately 5mg of each sample was weighed and 
suspended in 6ml PBS and placed into a shaking water bath 
(120 rpm) at 37 oC to mimic physiological conditions. At 
predetermined time intervals, the solution was centrifuged at 
11500 rpm for 30min. After centrifugation, 5ml of the 
supernatant was removed and 5ml of fresh PBS was added to 
the particles to re-suspend them. The paclitaxel content in the 
supernatant was extracted into 1ml DCM. The DCM with 
paclitaxel was then left to evaporate before addition of 2ml of 
the mobile phase which was subsequently filtered into HPLC 
vials for similar analysis as described for encapsulation 
efficiency. 
 
 
III. RESULTS AND DISCUSSION 
Many factors play a role in manipulating the particle 
formation during the SAS process. It was reported that the 
influencing factor in SAS is the extent of mixing and mass 
transfer between the solvent – antisolvent phases [12 – 13]. 
The thermodynamics and hydrodynamics effect on particle 
formation in SAS process is investigated in this study.  
 
A. Thermodynamics effect 
The diffusivity and viscosity are transport properties that 
affect mass transfer rates. Diffusivity in supercritical fluids 
is higher than a liquid solvent and hence a solid will 
dissolve more rapidly in a supercritical fluid. Diffusion 
coefficient of a supercritical fluid varies with temperature 
and pressure, and strongly influenced by density and 
viscosity [17]. In pharmaceutical applications, it is 
necessary to maintain low processing temperatures in order 
to prevent degradation of pharmaceutics. Therefore, we are 
interested to determine the effects of varying pressure on 
the particle formation process at a constant low processing 
supercritical temperature of 35 oC.  
 
SAS process was carried out at pressures of 73.8 bars 
(Critical pressure of CO2), 80 bars, 90 bars and 95 bars 
respectively. Figure 2a and b shows the particles obtained 
at 73.8 and 80 bars respectively. Microparticles were 
obtained for both cases. It was observed at these near-
critical conditions, the particles obtained had very rough 
surfaces. The particles obtained at 73.8 bars appear to be 
slightly agglomerated. 
 
At higher pressures, it was observed that particles 
obtained were less agglomerated. Figure 3a and 3b shows 
the particles obtained at 90 and 95 bars respectively. 
Figure 3c and 3d shows the close up of the surface 
morphologies for the particles in 3a and 3b respectively.  
 
In all 4 cases for varying pressure, microparticles of 
approximately 5-10 µm were obtained. The differences in 
surface morphology suggest a difference in the solvent 
removal rate during the SAS process. The rate of solvent 
removal is dependent on the miscibility of the organic 
solvent and antisolvent phases. The agglomeration of 
particles obtained at 73.8 bars may be due to the slower 
solvent removal rate as compared to higher pressures. 
Significantly less agglomeration was observed for 
pressures higher than 80 bars.  
 
B. Hydrodynamics effect 
The hydrodynamics have been found to influence 
particle morphologies [16]. In this study, the 
hydrodynamics of the SAS process was investigated by 
varying the liquid flow rates of the organic phase and also 
by application of ultrasonic vibration to the supercritical 
CO2 phase during the precipitation step. Varying liquid 
flow rates of the organic phase were applied to the SAS 
process at 90 bars and 35 oC to determine the relationship 
between flow rates and particle properties. Figure 4 shows 
 
TABLE 1. 
Summary of differences between modified SASEM setup in 
present study and SASEM. 
 
 Present study (Modified 
setup) 
SASEM 
High pressure 
cell volume 68.4 ml 80.0 ml 
Organic phase 
feeding system 
HPLC reciprocating 
pump 
High pressure piston 
device 
Sonicator Maximum 400W Probe tip 0.825mm 
Maximum 600W 
Probe tip 1.25mm 
Capillary ID 500 mm (stainless steel) 75 mm (fused quartz) 
Solvent 
removal 
CO2 – solvent solution 
removed from bottom of 
vessel 
CO2 – solvent solution 
removed from side of 
vessel 
Spray jet 
Jet directed away from 
sonicator vibrating 
surface (Horizontal jet) 
Capillary placed against 
the probe surface 
 
 
the SEM images of particles obtained at flow rates of 2, 4 and 
6 ml/min.  
 
From the SEM images, no significant differences were 
observed for particle size and morphology. However, upon 
careful observation, it was found that the particles may be 
divided into 2 main size clusters. Particles of around 1 µm and 
particles of around 2-10 µm. Figure 5 shows the size 
distribution of particles from liquid flow rates of 4 ml/min and 
6 ml/min. Particles around 1 µm and particles around 2-10 µm 
in size. Figure 5 shows the size distribution of particles from 
liquid flow rates of 4 ml/min and 6 ml/min. For both particle 
size distribution curves, a peak at approximately 1 µm was 
observed. However, at 6ml/min the second peak is at a smaller 
size then the corresponding one for 4ml/min. The overall 
mean and standard deviation of the particle size for samples 
from 6 ml/min is lower than the samples from 4 ml/min. The 
larger particles may be formed as a result of growth of 
particles from few particles during the precipitation process. 
Higher liquid flow rate enhances the mixing of the jet with the 
supercritical CO2 and hence reduces the size of particles. 
  
The application of ultrasonication during the SAS process 
was also evaluated. This process is similar to the SASEM 
process reported by Chattopadhyay and Gupta [7 – 11]. The 
main difference of the present setup is in the horizontal jet for 
organic phase instead of directing the jet at the ultrasonic 
probe vibrating surface. Figure 6 is a photograph taken of 
the jet breakup and mixing during the modified SASEM 
process used in present setup. The size and morphologies 
of particles obtained from SAS and modified SASEM 
were illustrated in Figure 7.    
 
The particle size is significantly reduced by the 
application of ultrasonication. Nanoparticles with much 
narrow size distribution were achieved using the modified 
SASEM setup. The recovery yield and sizes of particles 
obtained were summarized in table 2. The yield was 12.8% 
to 21.1% which is comparable to the yield for spray drying 
methods [18]. The main advantage of SAS over spray 
drying is the rapid removal of organic solvent without the 
need for high temperatures. The encapsulation efficiency 
of paclitaxel in the micro and nanoparticles fabricated 
using SAS/SASEM was very high up to 83.5%. 
 
C. Applications for controlled release 
The nanoparticles obtained using the modified SASEM 
process was further evaluated for their suitability for 
controlled release applications. The encapsulation and 
sustained release of a hydrophobic anticancer drug, 
paclitaxel, was employed to characterize the properties and 
release from PLA micro and nanoparticles. Paclitaxel is a 
promising anticancer drug with efficacy against a wide 
Fig. 2.  Representative SEM images of paclitaxel loaded PLA particles 
obtained from SAS at (a) 73.8 bars; (b) 80 bars 
(a) (b) 
Fig. 3.  Representative SEM images of paclitaxel loaded PLA particles 
obtained from SAS at (a) 90 bars; (b) 95 bars; (c) close up of particle 
surface for (a); (d) close up of particle surface for (b). 
 
(b) 
(c) (d) 
(a) 
(a) (b) 
(c) 
Fig. 4.  Representative SEM images of paclitaxel loaded particles obtained 
from SAS at liquid flow rate of (a) 2 ml/min; (b) 4 ml/min; (c) 6 ml/min 
TABLE 2.  
Paclitaxel loaded PLA samples obtained using modified SASEM 
process  
Sample 
Ultrasonic 
vibration 
amplitude (µm) 
Recovery 
Yield (%) 
Encapsulation 
efficiency (%) Size (nm) 
S1 0 21.1 70.0 ±3.5 4130 ± 198 
S2 30 18.1 67.7 ± 1.4 769 ± 210 
S3 60 14.6 56.4 ± 14.4 506 ± 163 
S4 90 12.8 83.5 ± 0.8 486 ± 134 
 
variety of carcinomas [18 – 24]. It works through the 
inhibition of DNA synthesis by stabilizing microtubule 
assembly [19]. However, its clinical application has been 
limited due to its hydrophobic nature. Its current formulation 
requires the use of an adjuvant, Cremophor® EL, which has 
been associated with several undesirable side effects [19, 21 – 
24]. One method to overcome the problems brought about by 
Cremophor® EL is to encapsulate paclitaxel in biodegradable 
polymers such PLA or poly (DL lactic-co-glycolic acid) 
(PLGA) in micro and nanoparticles. These biodegradable 
polymeric particles also have the advantage of providing 
sustained release of paclitaxel for chemotherapy [18, 21 – 24].  
 
The thermal properties, encapsulation efficiency and in vitro 
release profiles of the paclitaxel loaded PLA particles 
fabricated were studied. Thermal analysis is a useful tool for 
examine the dispersion of drugs in polymeric microsphere 
matrix [25, 26]. The thermogram properties of the particles 
fabricated in this study was analyzed using the differential 
scanning calorimetry (DSC). The exotherm for the paclitaxel 
and PLA used in this study are shown in Figure 8. Pure 
paclitaxel has a characteristic endothermic peak at 
approximately 223.0 oC [27] and the DSC analysis shows 
paclitaxel with an endothermic peak at 224.5 oC which is in 
close agreement with the literature value. The melting peak for 
pure PLA before processing was 178.7 oC.   
 
The thermogram analysis of the drug-encapsulated 
microparticles and nanoparticles allow us to determine 
whether most of the paclitaxel was molecularly dispersed in 
the polymer matrix or crystallized out as needles during the 
precipitation process. In Figure 8, the exotherm for blank PLA 
(without paclitaxel) and PLA (with 10% paclitaxel) 
fabricated using the supercritical antisolvent process were 
illustrated. The endothermic melting peak for the blank 
PLA particles was 175.8 oC which was approximately 3 oC 
lower then the untreated PLA particles. It was also 
observed that, with paclitaxel-loaded particles, the 
endothermic peak is further shifted by approximately 2 oC.  
 
The supercritical antisolvent process with ultrasonication 
did not significantly alter the polymeric structure for PLA. 
There was also no endothermic peak observed for the 
paclitaxel-loaded particles exotherm in the vicinity of 220 
– 230 oC, i.e., near the melting point of paclitaxel. 
Therefore, we can deduce that, in the fabrication of the 
paclitaxel-loaded PLA particles, there was no significant 
phase separation and no crystalline paclitaxel was present 
at 10% drug loading.  
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Fig. 5.  Particle size distribution obtained from liquid flow rates of (a) 
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Fig. 6.  High resolution photograph of modified SASEM process. 
The organic enters the high pressure vessel as a gaseous plume. The 
mixing between solvent and antisolvent is improved by the 
ultrasonic vibration. 
(a) (b) 
(c) (d) 
Fig. 7.  Representative SEM images of paclitaxel loaded PLA particles 
obtained at varying ultrasonic vibration amplitude (a) No ultrasonication; 
(b) 30 µm vibration amplitude; (c) 60 µm vibration amplitude; (b) 120 µm 
vibration amplitude. Note the difference in scale for Fig. 7a with Fig 7b-7c. 
The in vitro release profiles of the 10% paclitaxel samples 
fabricated at varying ultrasonic vibration amplitude were 
determined and are illustrated in Figure 9. In vitro release 
profiles of the paclitaxel-loaded particles were determined for 
up to 36 days release. As shown in Figure 9, the release of 
paclitaxel from S1 (sample prepared with no ultrasonic 
vibration) had an initial burst of 20% cumulative release in the 
first 2 days. The corresponding initial burst was approximately 
30% for samples S2 and S3. Beyond the 5th day of in vitro 
release, the release profiles of samples S2 and S3 seemed to be 
similar. The initial burst is primarily due to the diffusion out 
of paclitaxel close to the surface of the particles. Since particle 
sizes for samples S2 and S3 were much smaller than S1, it was 
reasonable to observe an increase in initial release profile with 
decrease in particle size. Subsequent release of paclitaxel from 
the polymer matrix is dependent upon the bulk erosion of the 
polymer. Since the polymer matrixes for all the samples were 
similar, the bulk erosion process is similar and hence the 
explanation for similar release profiles beyond 5th day of in 
vitro release. Further studies will be carried out to explain the 
release behavior in greater detail. 
 
 
IV. CONCLUSIONS 
Both thermodynamics and hydrodynamics effects of the 
SAS process was examined in this study. An increase in 
pressure from critical to supercritical conditions enhanced the 
surface morphology of particles achieved. The hydrodynamics 
was evaluated by studying the effects of varying liquid flow 
rates and ultrasonic vibration amplitude. In this study, it was 
observed that both size and size distribution are dependent on 
the hydrodynamics of the SAS process. The synergistic effect 
of combining flow rate and ultrasonic vibration amplitude for 
particle size control will be further evaluated in near future 
studies.  
 
The modified SASEM process has been applied 
successfully for fabricating PLA nanoparticles with paclitaxel 
loading for sustained release. The in vitro release profile of the 
samples show sustained release of paclitaxel for up to 36 days. 
 
 
ACKNOWLEDGEMENTS 
This research is supported by research grant C382-427-
003-091. The authors would like to thank Prof Yee C. 
Chiew and Dr Zhen Huang for their technical support in 
this work. The authors would also like to thank Prof 
Jefferson W. Tester (MIT, USA), Mr Jingwei Xie and Dr 
Michael T. Timko for their most helpful discussions in this 
study and Mr Brian Moyer (Thartech) for providing advice 
on the technology. 
 
 
REFERENCES 
[1] J. Jung and M. Perrut, “Particle design using supercritical fluids: 
Literature and patent survey” J. Supercritical Fluids. 20, pp 179 – 219, 
2001. 
[2] J. Richard and F. S. Dechamps, “Supercritical Fluid Processes for 
Polymer Particle Engineering – Applications in the Therapeutic Area”, in 
Colloidal biomolecules, biomaterials, and biomedical applications – 
edited by A. Elaissari. New York: M. Dekker, 2004, pp 429 – 475.  
[3] J. W. Tom and P. G. Debenedetti, “Particle Formation with 
Supercritical Fluids – A review”. J. Aerosol. Sci. 22, pp 555 – 584, 1991 
[4] P. G. Debenedetti, J.W. Tom and S. D. Yeo, “Rapid expansion of 
supercritical solutions (RESS): Fundamentals and Application” Fluid 
Phase Equilibria. 82, pp 311 – 321, 1993 
[5] T. W. Randolph, A.D. Randolph, M. Mebes and S. Yeung, “Sub-
micrometer-sized biodegradable particles of poly (L-lactic acid) via the 
gas antisolvent spray precipitation process” Biotechnol. Prog. 9, pp 429 – 
435, 1993 
[6] B. Subramaniam, S. Saim, R. A. Rajewski, and V. Stella, 
“Methods for a particle precipitation and coating using near-critical and 
supercritical antisolvents” Patent No. 5,833, 891, 1997 
[7] P. Chattopadhyay and R B. Gupta, “Production of antibiotic 
nanoparticles using supercritical CO2 as antisolvent with enhanced mass 
transfer” Ind. Eng Chem. Res. 40, pp 3530 – 3539, 2001 
[8] P. Chattopadhyay and R B. Gupta, “Production of griseofulvin 
nanoparticles using supercritical CO2 antisolvent with enhanced mass 
transfer” Int.  J. Pharma.  228, pp 19 – 31, 2001 
[9] P. Chattopadhyay and R B. Gupta, “Protein nanoparticles 
formation by supercritical antisolvent with enhanced mass transfer” 
AIChE Journal. 48 (2), pp 235 – 244, 2002 
[10] P. Chattopadhyay and R B. Gupta, “Supercritical CO2 based 
production of magnetically responsive micro- and nanoparticles for drug 
targeting” Ind. Eng. Chem. Res. 41, pp 6049 – 6058, 2002 
[11] P. Chattopadhyay and R B. Gupta, “Methods of forming 
nanoparticles and microparticles of controllable size using supercritical 
fluids and ultrasound”. Pub. No. 2002/0000681, 2002 
[12] E. Reverchon, G. Caputo and I. De Marco, “Role of phase 
behavior and atomization in the supercritical antisolvent precipitation” 
Ind. Eng. Chem. Res. 42, pp 6406 – 6414, 2003 
Fig. 8.  Thermogram properties for raw materials used and nanoparticles 
fabricated using the modified SASEM process. 
-20
-15
-10
-5
0
5
10
15
20
0 50 100 150 200 250 300
Temperature (oC)
Ex
ot
h
er
m
 (
m
W
)
Paclitaxel
PLA (before SAS process)
Sample S3 (Paclitaxel loaded
PLA with ultrasonication) 
Blank PLA with ultrasonication
 
0
10
20
30
40
50
60
0 5 10 15 20 25 30 35 40
Release time (days)
C
u
m
u
la
ti
ve
 r
el
ea
se
 (
%
)
S1
S2
S3
Fig. 9.  In vitro release profiles of paclitaxel loaded particles fabricated 
using modified SASEM process with ultrasonic vibration amplitude 0 
– 60 µm. 
[13] M. Henczka, J. Baldyga, B. Y. Shekunov, “Particle formation by 
turbulent mixing with supercritical antisolvent”, Chem. Eng. Sci. 60,  pp 2193 
– 2201, 2005 
[14] F. Ruchatz, P. Kleinebudde and B. W. Muller, “Residual solvent in 
biodegradable microparticles: Influence of process parameters on the residual 
solvent in microparticles produced by the aerosol solvent extraction system 
(ASES) process”, J. Pharma. Sci. 86 (1), pp 101 – 105, 1997. 
[15] Y. Perez de Diego, H. C. Pellikaan, F. E. Wubbolts, G. J. Witkamp 
and P. J. Jansens, “Operating regimes and mechanism of particle formation 
during the precipitation of polymers using the PCA process”, J. Supercritical 
fluids, 35, pp 147 – 156, 2005 
[16] E. Carretier, E. Badens, P. Guichardon, O. Boutin and G. Charbit. 
“Hydrodynamics of supercritical antisolvent precipitation: Characterization 
and influence on particle morphology”, Ind. Eng. Chem. Res. 42, pp 331 – 338, 
2003  
[17] F. P. Lucien and N. R. Foster, “Phase Behavior and Solubility” in 
Chemical Synthesis using supercritical fluids – edited by P. G. Jessop and W. 
Leitner. (1999) Wiley-VCH, pp 37-53.  
[18] L. Mu, S.S. Feng, “Fabrication, characterization and in vitro release 
of paclitaxel (Taxol ®) Poly (DL-lactic-co-glycolic acid) microspheres 
prepared by spray drying technique with lipid/ cholesterol emulsifiers”. J. 
Control. Rel. 76, pp 239 – 254, 2001 
[19] A. K. Singla, A. Garg and D. Aggarwal, “Paclitaxel and its 
formulations”, Int. J. Pharma. 235, pp 179 – 192, 2002 
[20] R. B. Ewesuedo, M. J. Ratain, Systemically administered drug, Drug 
Delivery systems in cancer therapy, edited by D. M. Brown (2004) pp 3 – 13, 
Humana press  
[21] L. Mu, S. S. Feng, PLGA/TPGS Nanoparticles for controlled release 
of paclitaxel, Pharma. Res.  20, pp 1864 – 1972, 2003 
[22] L. Mu, S. S. Feng, “A novel controlled release formulation for the 
anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing vitamin 
E TPGS”, J. Control. Rel. 86 (2003) pp 33 – 48, 2003 
[23] S. S. Feng, L. Mu, K. Y. Win, G. Huang, “Nanoparticles of 
biodegradable polymers for clinical administration of paclitaxel”, Curr. Med. 
Chem. 11, pp 413 – 424, 2004 
[24] J. Wang, C. W. Ng, K. Y. Win, P. Shoemakers, T. K. Y. Lee, S. S. 
Feng, C. H. Wang, “Release of paclitaxel from polylactide-co-glycolide 
(PLGA) microparticles and discs under irradiation”, J. Microencapsulation. 
20, pp 317 – 327, 2003 
[25] C. Dubernet, “Thermoanalysis of microspheres”, Thermochimica 
Acta, 245,  pp 259 – 269, 1995 
[26] O. I. Corrigan, “Thermal analysis of spray dried products”, 
Thermochimica Acta, 248, pp 245 – 258, 1995 
[27] R. T. Liggins, W. L. Hunter, H. M. Burt, “Solid state characterization 
of paclitaxel’, J. Pharma. Sci,  86, pp 1458 – 1463, 1997 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
